“`html Financial News Update UMC: Operational Enhancements and Market Expansion Drive Positive Outlook Investment Bank TA SECURITIES TP (Target Price) RM0.51 (+50.0%) Last Traded RM0.34 Recommendation BUY PhillipCapital, the investment bank issuing the research report, has reiterated its “BUY” recommendation for the company, maintaining an unchanged target price of RM0.51. This positive outlook is primarily…
Financial News Report UMC: Earnings Performance Meets Expectations, Target Price Increased on Strategic Outlook Investment Bank PhillipCapital TP (Target Price) RM0.51 (+48.8%) Last Traded RM0.34 Recommendation BUY Core net profit for the first quarter of fiscal year 2026 (1QFY26) was reported at RM2 million, reflecting an 8% year-on-year decline but aligning with both internal and…
Medical Device Manufacturer Eyes Stronger Margins and Expanded Markets UMC: Medical Device Manufacturer Eyes Stronger Margins and Expanded Markets Investment Bank TA SECURITIES TP (Target Price) RM0.25 (+25.0%) Last Traded RM0.20 Recommendation BUY An analysis from TA SECURITIES maintains a “BUY” recommendation for a prominent medical device manufacturer, projecting significant growth driven by capacity expansion,…
Greetings, fellow investors and healthcare enthusiasts! Today, we’re diving deep into the latest financial pulse of UMediC Group Berhad, a prominent player in Malaysia’s medical device and consumables sector. The company has just unveiled its unaudited consolidated results for the third quarter ended 30 April 2025, and there’s plenty to unpack, from a notable rise…